Kite Pharma, Inc. (KITE) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
laurvp laurvp 05/31/2015 1 week $55.15 $62.19 +12.77% 12 Ended
Fizzled Fizzled 04/08/2015 3 months $55.59 +17.49% N/A Ended
MushtaqChoudhury MushtaqChoudhury 01/27/2015 3 months $71.37 $60.58 -15.12% -15 Ended
Comments: engineered autologous cell therapy, pricing power on drugs, most phase 3 trails in 2015
Netteligent Netteligent 01/14/2015 1 month $86.66 $62.59 -27.77% 27 Ended
Magnat Magnat 12/19/2014 3 months $52.17 $63.52 +21.76% 21 Ended
markkabbash markkabbash 10/02/2014 1 week $28.31 $34.97 +23.53% 23 Ended
PunnyFekry PunnyFekry 08/26/2014 1 month $22.30 $26.61 +19.33% 19 Ended
Vetrdotcom Vetrdotcom 06/20/2014 3 months $28.59 $26.53 -7.21% -7 Ended
Comments: Great gains in $KITE's first day

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.